An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type 1 diabetes, hepatitis ...

AbbVie has agreed to buy Capstan Therapeutics for up to $2.1 billion, expanding its pipeline with a potential first-in-class ...

AbbVie (ABBV) on Monday announced that it has entered into a definitive agreement to acquire privately held clinical-stage ...

ARGX-119 in congenital myasthenic syndromes: Amsterdam, the Netherlands Tuesday, July 1, 2025, 18:00 Hrs [IST] argenx SE, a global immunolo ...

Autoimmune disorders occur when the immune system mistakenly attacks the body's own tissues, leading to chronic conditions such as rheumatoid arthritis, type 1 diabetes, and multiple sclerosis ... the ...

While there is currently no cure for multiple sclerosis, researchers continue to discover clues to give a better ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study ...

Scientific research is at the heart of Israel’s success and has worldwide benefits. Our work will continue despite adversity.

Stem cell therapies offer emerging hope for systemic sclerosis, with autologous and mesenchymal options under investigation ...

Many people with multiple sclerosis (MS) may wonder whether trying a certain diet — or eliminating a certain food group from their diet — can ward off MS symptoms, like fatigue or cognitive ...

The FDA has granted accelerated approval to linvoseltamab-gcpt (Lynozyfic) for the treatment of adult patients with ...